Table 3 Assessment of functional outcome according to the Patient-Rated Hand/Wrist Evaluation (PRWHE)
Variable | Group A (Active) | Group B (Placebo) | p-value |
|---|---|---|---|
Pain Subscale* (mean, [95% CI**]) | |||
- Baseline | 25.7 [21.4; 30.0] | 26.8 [22.7; 31.0] | 0.708 |
- 6 weeks | 16.0 [12.4; 19.5] | 15.4 [11.3; 19.4] | 0.824 |
- 9 weeks | 14.6 [11.1; 18.0] | 15.4 [11.1; 19.6] | 0.770 |
- 12 weeks | 10.7 [7.4; 14.0] | 10.2 [6.6; 13.9] | 0.851 |
- 24 weeks | 8.3 [4.9; 11.7] | 7.2 [4.3; 10.1] | 0.631 |
- 52 weeks | 4.6 [2.1; 7.1] | 3.7 [1.1; 6.3] | 0.626 |
Function Subscale† (mean, [95% CI**]) | |||
- Baseline | 74.3 [67.9; 81.0] | 68.1 [59.8; 76.3] | 0.235 |
- 6 weeks | 52.2 [44.3; 60.1] | 47.5 [38.4; 56.5] | 0.426 |
- 9 weeks | 29.3 [21.0; 37.6] | 34.9 [23.5; 46.3] | 0.411 |
- 12 weeks | 16.6 [9.3; 23.9] | 20.8 [12.2; 29.3] | 0.456 |
- 24 weeks | 8.1 [4.0; 12.1] | 6.4 [2.1; 10.7] | 0.569 |
- 52 weeks | 2.8 [0.8; 4.7] | 3.4 [0.5; 6.2] | 0.724 |
Total Score‡ (mean, [95% CI**]) | |||
- Baseline | 62.9 [56.5; 69.3] | 60.9 [53.1; 68.7] | 0.687 |
- 6 weeks | 42.1 [35.5; 48.7] | 39.1 [31.0; 47.2] | 0.565 |
- 9 weeks | 29.2 [22.1; 36.4] | 32.8 [23.4; 42.2] | 0.531 |
- 12 weeks | 19.0 [12.6; 25.4] | 20.6 [13.2; 28.0] | 0.738 |
- 24 weeks | 12.3 [7.1; 17.6] | 10.4 [5.7; 15.1] | 0.586 |
- 52 weeks | 5.9 [2.7; 9.2] | 5.4 [1.5; 9.3] | 0.832 |